Concerta
Product Images NDC 54868-4957

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Concerta (NDC 54868-4957). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (18 mg Tablet Label)

Concerta 18 mg extended-release tablets by Physicians Total Care, Inc. The label identifies the active ingredient as Methylphenidate HCl and contains 30 tablets. It includes dosage information, storage instructions, a barcode, lot number, and expiration date markings. The label also states that the product is federally controlled and not dispensed without prescription.*

FDA Label Image

Principal Display Panel (36 mg Tablet Label)

Concerta 36 mg extended-release tablets packaging label by Physicians Total Care, Inc. The label includes the active ingredient methlyphenidate HCl, the quantity of 60 tablets, and a caution stating federal law prohibits dispensing without a prescription. It also shows storage instructions, a barcode, lot number, and manufacturer information.*

FDA Label Image

Principal Display Panel (54 mg Tablet Label)

Concerta 54 mg extended-release tablets by Physicians Total Care, Inc. The white medication bottle label includes the product name, strength, dosage form, and quantity of 30 tablets. The label displays NDC information, a caution about federal law restricting dispensing without prescription, and storage instructions. It also features a barcode and lot and expiration dates.*

FDA Label Image

Principal Display Panel (27 mg Tablet Label)

Concerta 27 mg extended-release tablets label from Physicians Total Care, Inc. The label shows the proprietary name Concerta and strength 27 mg. It includes dosing information, a caution about federal law restricting dispensing without a prescription, and storage instructions. The label also features a barcode, lot number, and expiration date.*

FDA Label Image

Chemical Structure (Concerta 01)

Chemical structure of Concerta active ingredient showing molecular bonds and groups, including a methoxy group, a phenyl ring, and a piperidine ring, with an associated hydrochloride (HCl) label.*

FDA Label Image

Figure 1 (Concerta 02)

A line graph comparing mean plasma methylphenidate concentration (ng/mL) over time (hours) for CONCERTA 18 mg once daily versus methylphenidate 5 mg taken three times daily. Concentration peaks and declines are shown for both dosing regimens over a 32-hour period.*

FDA Label Image

Figure 2 (Concerta 03)

A bar chart comparing the Inattention/Overactivity Scale scores between Concerta (once daily) and placebo groups across three studies. Each study shows two bars representing Concerta and placebo, illustrating differences in symptom scores with error bars indicating variability.*

FDA Label Image

Figure 3 (Concerta 04)

A line graph comparing the combined attention subscale over 12 hours post initial dose between Concerta once daily and placebo. The vertical axis measures attention levels from more attentive to less attentive, and the horizontal axis represents hours after dosing. The graph shows two distinct trends for each treatment group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.